About Dr. Qu Hongping
Dr. Qu Hongping (矞洪平) is one of China's most distinguished intensivists and the Director of the Department of Critical Care Medicine (ICU) at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. He holds the title of Chief Physician and Professor and is nationally recognized as a leading authority on sepsis, acute respiratory distress syndrome (ARDS), and multiorgan failure management.
Over a career spanning more than two decades at the forefront of Chinese critical care medicine, Dr. Qu has established Ruijin Hospital's ICU as one of the most sophisticated and research-active intensive care units in China. He is particularly renowned for his expertise in sepsis and septic shock management, mechanical ventilation optimization, and extracorporeal life support (ECMO) — areas where his contributions have shaped national clinical guidelines and influenced ICU practice across China.
For international patients requiring intensive care during or after complex surgery, or those with life-threatening medical conditions requiring the highest level of monitoring and organ support, Dr. Qu's department provides world-class critical care that is a critical safety net for all major clinical programs at Ruijin Hospital.
Professional Positions and Affiliations
- Director, Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Vice Chairman, Chinese Society of Critical Care Medicine
- Chairman, Sepsis Committee, Chinese Society of Critical Care Medicine
- Editorial Board Member: Critical Care Medicine, Intensive Care Medicine, Chinese Critical Care Medicine
- Member, Society of Critical Care Medicine (SCCM)
- Member, European Society of Intensive Care Medicine (ESICM)
- Member, Surviving Sepsis Campaign (SSC) Guidelines Committee
Specialties and Clinical Expertise
- Sepsis and Septic Shock — early goal-directed therapy, source control, antibiotic stewardship, vasopressor optimization, and corticosteroid therapy; implementation of Surviving Sepsis Campaign bundles; biomarker-guided management (procalcitonin, lactate)
- Acute Respiratory Distress Syndrome (ARDS) — lung-protective ventilation (low tidal volume, PEEP optimization), prone positioning, neuromuscular blockade, and ECMO for refractory ARDS
- Mechanical Ventilation — invasive and non-invasive ventilation; ventilator weaning protocols; high-flow nasal oxygen (HFNO); airway management in the critically ill
- Extracorporeal Life Support (ECMO) — veno-venous ECMO for respiratory failure, veno-arterial ECMO for cardiogenic shock and cardiac arrest; ECMO cannulation and management
- Multiorgan Failure — renal replacement therapy (CRRT), hepatic support, and integrated multiorgan management in the critically ill
- Post-Surgical Critical Care — ICU management after major oncologic surgery (hepatectomy, pancreatectomy, esophagectomy), cardiac surgery, and organ transplantation
- Infectious Disease in the ICU — multidrug-resistant organism (MDRO) management, antifungal therapy, and infection control in the ICU setting
- Nutrition and Metabolic Support — early enteral nutrition, parenteral nutrition, and metabolic monitoring in critically ill patients
Academic and Research Contributions
Dr. Qu Hongping has published over 160 peer-reviewed papers in leading international critical care journals, with a particular focus on sepsis epidemiology in China, the optimization of mechanical ventilation in ARDS, and the outcomes of ECMO in Chinese patients. His landmark epidemiological study on sepsis incidence and mortality in Chinese ICUs — one of the largest of its kind in Asia — has been widely cited and has contributed to international understanding of sepsis burden in developing healthcare systems.
He serves on the Surviving Sepsis Campaign (SSC) Guidelines Committee — the international body that produces the world's most widely used sepsis management guidelines — representing China's perspective and contributing data from Chinese patient populations. He has led multicenter trials on biomarker-guided antibiotic therapy and ECMO outcomes in Chinese patients, and is a regular invited speaker at the Society of Critical Care Medicine (SCCM) Annual Congress and the European Society of Intensive Care Medicine (ESICM) annual meeting (LIVES).
Hospital: Ruijin Hospital Critical Care Department
Under Dr. Qu's leadership, Ruijin Hospital's Critical Care Department operates:
- A large Medical-Surgical ICU with advanced hemodynamic monitoring (PiCCO, Swan-Ganz catheter, point-of-care echocardiography)
- A dedicated ECMO Program with 24/7 cannulation capability for respiratory and cardiac failure
- A Continuous Renal Replacement Therapy (CRRT) Program for acute kidney injury
- A Sepsis Response Team for rapid identification and treatment of sepsis across the hospital
- Close integration with Cardiac Surgery ICU, Neurosurgical ICU, and Transplant ICU
Why International Patients Benefit from Dr. Qu Hongping's Department
- Surviving Sepsis Campaign Guidelines Committee member — directly contributing to and implementing the world's leading sepsis guidelines
- ECMO expertise — 24/7 capability for the most severe respiratory and cardiac failure
- Post-surgical critical care excellence — essential safety net for complex oncologic, cardiac, and transplant surgery
- SCCM and ESICM member — internationally credentialed and aligned with global critical care standards
- High-volume, high-complexity center — experience with the most challenging critical care scenarios
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
- ICU Access: Critical care is provided as part of inpatient surgical or medical admission; CMCS can facilitate family communication and interpretation during ICU stays
- Languages: Mandarin Chinese; English interpretation provided by CMCS for family consultations
- Emergency: 24/7 emergency department with direct ICU admission pathway for critically ill patients
How CMCS Can Help
For international patients or their families navigating a critical care admission at Ruijin Hospital, CMCS provides essential support including on-site interpretation for family consultations with the ICU team, daily medical update translation, coordination with the patient's home country physicians, and logistical support for family members traveling to Shanghai. We also assist with post-ICU step-down care coordination and repatriation planning when appropriate.
📧 Contact us: contract@medicalsh.com
🌐 medicalsh.com
0 則留言